Cargando…

The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening

BACKGROUND: Cystic fibrosis (CF) is caused by mutations in the gene encoding for the CF transmembrane conductance regulator (CFTR) protein, which acts as a chloride channel after activation by cyclic AMP (cAMP). Newborn screening programs for CF usually consist of an immunoreactive trypsinogen (IRT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sermet-Gaudelus, Isabelle, Roussel, Delphine, Bui, Stéphanie, Deneuville, Eric, Huet, Frédéric, Reix, Philippe, Bellon, Gabriel, Lenoir, Gérard, Edelman, Aleksander
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1599715/ https://www.ncbi.nlm.nih.gov/pubmed/17018149 http://dx.doi.org/10.1186/1471-2431-6-25

Ejemplares similares

149* 2009 H1N1 influenza A in cystic fibrosis patients. A French collaborative study
por: Bucher, J., et al.
Publicado: (2011)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
por: Saussereau, Emilie Lyne, et al.
Publicado: (2013)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2007)

Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy
por: Bucher, Julie, et al.
Publicado: (2016)

Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort
por: Cornet, Matthieu, et al.
Publicado: (2022)

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease
por: Gauthier, Sebastien, et al.
Publicado: (2020)

Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease
por: Reynolds, Wanda F., et al.
Publicado: (2006)

Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, I., et al.
Publicado: (2018)

A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients
por: Guerrera, Ida Chiara, et al.
Publicado: (2009)

Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
por: Sermet-Gaudelus, I, et al.
Publicado: (1999)

Mycobacterium abscessus and Children with Cystic Fibrosis
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2003)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
por: Pranke, Iwona, et al.
Publicado: (2018)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry
por: Vongthilath, Réchana, et al.
Publicado: (2019)

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2021)

Mucoviscidosis: fisiopatología, genética, aspectos clínicos y terapéuticos
por: Noël, S., et al.
Publicado: (2020)

Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants
por: Baatallah, Nesrine, et al.
Publicado: (2022)

Editorial: New insights into caring for pediatric patients with cystic fibrosis
por: Bui, Stephanie, et al.
Publicado: (2023)

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

An unexpected effect of TNF-α on F508del-CFTR maturation and function
por: Bitam, Sara, et al.
Publicado: (2015)

Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
por: Marguet, Christophe, et al.
Publicado: (2021)

(CF)(2) architecture: contextual collaborative filtering
por: Bachmann, Dennis, et al.
Publicado: (2018)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice
por: da Cunha, Mélanie Faria, et al.
Publicado: (2022)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis
por: Simonin, Juliette, et al.
Publicado: (2019)

Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial
por: Quittner, Alexandra, et al.
Publicado: (2015)

Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
por: Pranke, Iwona M., et al.
Publicado: (2017)

Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis
por: Simonin, Juliette, et al.
Publicado: (2019)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Proteomic profiling of sweat in patients with cystic fibrosis provides new insights into epidermal homoeostasis
por: Cornet, Matthieu, et al.
Publicado: (2022)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas
por: Evans, Ieuan E. S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ls23th9i497tmsb1aqrdiretv5